Literature DB >> 19177252

CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients.

Caroline Moreau1, Philippe Gosset, Véronique Brunaud-Danel, Philippe Lassalle, Benoist Degonne, Alain Destee, Luc Defebvre, David Devos.   

Abstract

Our objective was to assess the regulation of the hypoxia response of angiogenic and inflammatory factors from 76 cerebrospinal fluids (CSF) of sporadic amyotrophic lateral sclerosis (ALS) patients with different respiratory status. We first analysed the hypoxia response capacity by measuring CSF levels of angiogenin (ANG), VEGF, angiopoietin-2 (ANG-2) and PGE-2 in 40 ALS patients according to their hypoxaemia level and compared it with 40 neurological controls. We then compared the ANG, VEGF, EPO and ANG-2 CSF levels of 36 other ALS patients, divided into three groups with either 1) normoxaemia, 2) intermittent desaturation in the absence of hypoxaemia, or 3) chronic hypoxaemia with or without desaturation. We demonstrated a lack of up-regulation of both ANG and VEGF during hypoxaemia in ALS, compared with hypoxaemic controls. In contrast, PGE-2 and ANG-2 levels were increased in both hypoxaemic ALS patients and controls. ANG and VEGF levels did not increase in patients with long disease durations and with intermittent or chronic hypoxaemia. ANG-2 and EPO levels were up-regulated early in intermittent hypoxaemia and late in chronic hypoxaemia, respectively. Our results suggest alteration of the HIF-1alpha-mediated response to hypoxia during sporadic ALS, whereas the NFK-B pathway seems early activated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177252     DOI: 10.1080/17482960802651725

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  13 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  Spinal vascular endothelial growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase and Akt signaling.

Authors:  Erica A Dale-Nagle; Irawan Satriotomo; Gordon S Mitchell
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

Review 3.  Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Lucas T Vu; Robert Bowser
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations.

Authors:  Nicola Ticozzi; Cinzia Tiloca; Niccolò E Mencacci; Claudia Morelli; Alberto Doretti; Daniela Rusconi; Claudia Colombrita; Davide Sangalli; Federico Verde; Palma Finelli; Stefano Messina; Antonia Ratti; Vincenzo Silani
Journal:  J Neurol       Date:  2012-07-01       Impact factor: 4.849

5.  Vascular disruption and the role of angiogenic proteins after spinal cord injury.

Authors:  Michelle T L Ng; Anthea T Stammers; Brian K Kwon
Journal:  Transl Stroke Res       Date:  2011-10-13       Impact factor: 6.829

Review 6.  Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis.

Authors:  Ana Catarina Pronto-Laborinho; Susana Pinto; Mamede de Carvalho
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

Review 7.  The Potential of Angiogenin as a Serum Biomarker for Diseases: Systematic Review and Meta-Analysis.

Authors:  Dongdong Yu; Yikai Cai; Wei Zhou; Jinghao Sheng; Zhengping Xu
Journal:  Dis Markers       Date:  2018-03-15       Impact factor: 3.434

8.  YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression.

Authors:  Pol Andrés-Benito; Raúl Domínguez; Maria J Colomina; Franc Llorens; Mònica Povedano; Isidre Ferrer
Journal:  Aging (Albany NY)       Date:  2018-09-13       Impact factor: 5.682

9.  Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study.

Authors:  Teresa Holm; André Maier; Paul Wicks; Dirk Lang; Peter Linke; Christoph Münch; Laura Steinfurth; Robert Meyer; Thomas Meyer
Journal:  Interact J Med Res       Date:  2013-04-17

10.  CSF Levels of Angiopoietin-2 Do Not Differ between Patients with CSF Fluid Leakage Syndrome and Controls.

Authors:  Refik Pul; Özlem Yildiz; Franco Morbiducci; Thomas Skripuletz; Philipp Schwenkenbecher; Martin Stangel; Friedrich Götz; Georg Berding; Corinna Trebst; Frank Donnerstag
Journal:  Dis Markers       Date:  2015-09-10       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.